- Trials with a EudraCT protocol (455)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (32)
455 result(s) found for: WASH.
Displaying page 1 of 23.
EudraCT Number: 2007-002853-21 | Sponsor Protocol Number: RGHT000405 | Start Date*: 2007-09-03 |
Sponsor Name:Belfast Health & Social Care Trust [...] | ||
Full Title: A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults | ||
Medical condition: Colonization with methicillin-resistant Staphylococcus aureus (MRSA) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-004319-33 | Sponsor Protocol Number: D5613C00001 | Start Date*: 2014-04-28 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase 2b, Randomized, Double blind, Placebo-controlled, Parallel group, Multicentre Dose finding Study to evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in E... | |||||||||||||
Medical condition: Hyperphosphatemia in patients with end-stage renal disease on hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004023-31 | Sponsor Protocol Number: LPS-Fluenz | Start Date*: 2016-01-06 |
Sponsor Name:Radboudumc | ||
Full Title: The effects of endotoxin challenge on the immune response elicited by a subsequent challenge with Fluenz™ in healthy volunteers, a pilot study | ||
Medical condition: Inflammatory conditions in general and immunosuppressive conditions is particular | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004862-89 | Sponsor Protocol Number: mirtazapine1 | Start Date*: 2015-02-16 |
Sponsor Name:KULeuven | ||
Full Title: The effect of mirtazapine (REMERGON®) on gastric motility and satiation in healthy subjects | ||
Medical condition: Functional Dyspepsia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005221-29 | Sponsor Protocol Number: Sevoflurane vs. Desflurane | Start Date*: 2007-02-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Curve di Wash-in/wash-out e tempi di recupero dopo anestesia con Sevoflurane vs. Desflurane in pazienti affetti da obesita' patologica | |||||||||||||
Medical condition: Pazienti affetti da obesita' patologica e candidati ad intervento di by-pass bilio-intestinale. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001721-31 | Sponsor Protocol Number: SPON-AK-0420 | Start Date*: 2020-05-01 | |||||||||||
Sponsor Name:Hampshire Hospitals NHS TRust | |||||||||||||
Full Title: Can a sinus rinse and mouth wash reduce viral load in COVID-19 positive individuals? | |||||||||||||
Medical condition: Covid-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004934-40 | Sponsor Protocol Number: 20072651 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part B | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism causes by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015821-34 | Sponsor Protocol Number: 6520-9961-03 | Start Date*: 2010-07-13 |
Sponsor Name:MEDICE Arzneimittel GmbH & Co. KG | ||
Full Title: Dosisfindungsstudie zu Nicotinamid bei dialysepflichtigen Patienten mit Hyperphosphatämie | ||
Medical condition: Hyperphosphatämie bei dialysepflichtigen Patienten | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002589-30 | Sponsor Protocol Number: CHUBX2015/17 | Start Date*: 2018-01-29 |
Sponsor Name:CHU DE BORDEAUX | ||
Full Title: Dynamic Contrast enhanced ultrasound for predict and assess rectal cancer response after neo-adjuvant chemoradiation – RECT | ||
Medical condition: Rectal Cancer | ||
Disease: | ||
Population Age: | Gender: | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004606-18 | Sponsor Protocol Number: WASH-OUT | Start Date*: 2018-06-19 | |||||||||||
Sponsor Name:UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA | |||||||||||||
Full Title: Terapia di disassuefazione con metilprednisolone e diazepam ev in pazienti affetti da cefalea cronica con uso eccessivo di sintomatici | |||||||||||||
Medical condition: Emicrania Cronica e Cefalea da Iperuso di Farmaci | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002848-22 | Sponsor Protocol Number: MV-004 | Start Date*: 2020-12-03 | |||||||||||
Sponsor Name:Meissa Vaccines Inc. | |||||||||||||
Full Title: A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Prophylactic Efficacy of MV-012-968 Against Respiratory Syncytial Virus (RSV) Infection in the Virus Challe... | |||||||||||||
Medical condition: Respiratory Syncytial Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004852-13 | Sponsor Protocol Number: 2012001 | Start Date*: 2014-06-24 |
Sponsor Name:Anestesikliniken | ||
Full Title: Low fresh gas flow during elective general anaesthesia - A pilot study comparing Desflurane and Sevoflurane for anaesthetic controllability during wash-in and for haemodynamic control during elec... | ||
Medical condition: General anaesthesia time to onset - wash-in | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003194-33 | Sponsor Protocol Number: VAC18193RSV2002 | Start Date*: 2017-10-03 |
Sponsor Name:Janssen Vaccines and Prevention B.V. | ||
Full Title: An Exploratory, Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infe... | ||
Medical condition: Prophylactic respiratory syncytial virus (RSV) vaccine. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001644-80 | Sponsor Protocol Number: FG-506-06-41 | Start Date*: 2004-12-15 | |||||||||||
Sponsor Name:Fujisawa GmbH | |||||||||||||
Full Title: Clinical study on tacrolimus ointment over the long-term “Control Study - Children” Revised version of FG-506-06-39 | |||||||||||||
Medical condition: Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000227-71 | Sponsor Protocol Number: ITCC-059 | Start Date*: 2016-09-02 | |||||||||||
Sponsor Name:Erasmus Medical Center | |||||||||||||
Full Title: A phase I/II study of Inotuzumab Ozogamicin as a single agent and in combination with chemotherapy for pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia | |||||||||||||
Medical condition: pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) DE (Trial now transitioned) IE (Trial now transitioned) AT (Trial now transitioned) SE (Trial now transitioned) DK (Trial now transitioned) ES (Ongoing) CZ (Ongoing) GB (GB - no longer in EU/EEA) FR (Trial now transitioned) IT (Trial now transitioned) NO (Trial now transitioned) FI (Trial now transitioned) PT (Prematurely Ended) BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020299-42 | Sponsor Protocol Number: KKS-135 | Start Date*: 2011-08-30 | |||||||||||
Sponsor Name:Philipps-University Marburg | |||||||||||||
Full Title: A randomized, placebo-controlled, double-blind, multi-center trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA (NIC-PD) | |||||||||||||
Medical condition: Early PD subjects within 18 months of diagnosis and not expected to require dopamine agonist or levodopa therapy for 1 year, with Hoehn and Yahr stage <2, with stable (>2 months) MAO-B inhibitor th... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000907-41 | Sponsor Protocol Number: DM/PR/3301/003/05 | Start Date*: 2006-06-13 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: A single dose, randomised, double blind, double dummy, placebo-controlled, three-period crossover clinical study, comparing the efficacy, safety and tolerability of Formoterol-HFA pMDI 12 microgram... | |||||||||||||
Medical condition: Persistent moderate to severe childhood asthma (5 to 12 years of age, inclusive) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020220-22 | Sponsor Protocol Number: H6D-MC-LVIR | Start Date*: 2010-12-21 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men with Signs and Symptoms of Be... | |||||||||||||
Medical condition: Benign Prostatic Hyperplasia (BPH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023614-31 | Sponsor Protocol Number: IPR25 | Start Date*: 2011-03-09 | |||||||||||
Sponsor Name:MOLMED | |||||||||||||
Full Title: NGR019: Randomized double-blind phase II study of NGR-hTNF versus placebo as maintenance treatment in advanced malignant pleural mesothelioma (MPM) | |||||||||||||
Medical condition: Advanced MPM patients with non-progressive disease after six cycles of a first-line, pemetrexed-based regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001039-30 | Sponsor Protocol Number: BetHäm2012 | Start Date*: 2013-03-06 | |||||||||||
Sponsor Name:Hospital of Goethe-Universitiy | |||||||||||||
Full Title: BetHäm2012: A monocenter, single-blind, randomized, 2-armed, placebo-controlled, cross-over study to investigate coagulation markers in patients with haemophilia A after administration of Betain | |||||||||||||
Medical condition: In this study patients with haemophilia A are included. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
